The consequences of delayed treatment in doxorubicin extravasation
Sign Up to like & getrecommendations! Published in 2020 at "European Journal of Plastic Surgery"
DOI: 10.1007/s00238-020-01715-y
Abstract: Doxorubicin (Adriamycin) is an anthracycline chemotherapy agent used for the treatment of several cancers including haematological malignancies. Extravasation is a well-recognized and possibly serious complication of administered intravenous therapies, especially in chemotherapeutic agents. Drug extravasation… read more here.
Keywords: doxorubicin extravasation; treatment; treatment doxorubicin; tissue ... See more keywords